VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,051,359 | -9.0% | 295,504 | +6.5% | 0.00% | 0.0% |
| Q2 2023 | $4,453,281 | +196.8% | 277,463 | +43.5% | 0.00% | – |
| Q1 2023 | $1,500,668 | -38.2% | 193,385 | +54.1% | 0.00% | -100.0% |
| Q4 2022 | $2,428,057 | -0.8% | 125,481 | +9.2% | 0.00% | 0.0% |
| Q3 2022 | $2,448,000 | +59.9% | 114,870 | +2.1% | 0.00% | – |
| Q2 2022 | $1,531,000 | -40.4% | 112,470 | +2.8% | 0.00% | – |
| Q1 2022 | $2,570,000 | +23.6% | 109,407 | +40.5% | 0.00% | – |
| Q4 2021 | $2,080,000 | +102.1% | 77,853 | +31.3% | 0.00% | – |
| Q3 2021 | $1,029,000 | – | 59,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
| Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
| Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
| Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
| Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
| Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
| Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
| Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |